We are live on
!
Find out more
PS
Peter Svennilson Portfolio holdings
AUM
$1.23B
1-Year Est. Return
301.34%
This Fund
S&P 500
This Quarter
Est. Return
-15.48%
1 Year Est. Return
+301.34%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$113M
AUM Growth
–
Cap. Flow
+$140M
Cap. Flow
% of AUM
123.64%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
4
New
4
Increased
–
Reduced
–
Closed
–
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
GRTS
Gritstone bio, Inc. Common Stock
GRTS
|
+$59.2M |
| 2 |
Arcus Biosciences
RCUS
|
+$41.3M |
| 3 |
CNST
Constellation Pharmaceuticals, Inc.
CNST
|
+$28.2M |
| 4 |
IMDZ
Immune Design Corp.
IMDZ
|
+$11.5M |
Top Sells
No sells this quarter
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 92.39% |
Similar funds
CT
CAW
VIM
SFSG
KFA
11A
TI
IA
Peter Svennilson's Q4 2018 Portfolio in Review
Q4 2018 is the first quarter with a 13F filing on record for Peter Svennilson, which disclosed 4 positions worth $113M. Its ten largest holdings account for 100% of the portfolio.
Its largest position is Gritstone bio, Inc. Common Stock: 3,102,934 shares worth $47.9M.
By sector, the portfolio is most concentrated in Healthcare at 92% of assets.
- Peter Svennilson's largest Q4 2018 buy was Gritstone bio, Inc. Common Stock: 3,102,934 shares worth $47.9M.
- Peter Svennilson's ten largest holdings make up 100% of its $113M portfolio in Q4 2018.
- Peter Svennilson disclosed 4 positions in Q4 2018, its first 13F filing on record.
Based on Peter Svennilson's 13F filing for Q4 2018, filed 13 Feb 2019.